Expediting the chromatographic analysis of COVID-19 antibody therapeutics with ultra-short columns, retention modeling and automated method development

The COVID-19 pandemic necessitated the emergency use authorization (EUA) of several new therapeutics and vaccines. Several monoclonal antibodies (mAbs) were among those authorized for use, and they have served a purpose to provide passive immunity and to help minimize dangerous secondary effects in...

Descripción completa

Detalles Bibliográficos
Autores principales: Duivelshof, Bastiaan, Zöldhegyi, Arnold, Guillarme, Davy, Lauber, Matthew, Fekete, Szabolcs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465490/
https://www.ncbi.nlm.nih.gov/pubmed/36115204
http://dx.doi.org/10.1016/j.jpba.2022.115039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465490/
https://www.ncbi.nlm.nih.gov/pubmed/36115204
http://dx.doi.org/10.1016/j.jpba.2022.115039

Ejemplares similares